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Introduction: The aim of the current work was to review the clinical profile, 
aetiological classification, as well as the management of Egyptian paediatric patients 
with disorders of sex development (DSD) presenting at a tertiary centre in Cairo. 
Material and methods: The study was a cross-sectional observational study that 
included Egyptian patients who attended the Endocrinology clinic during a period of 
one year from January to December 2019. All patients with overt genital ambiguity 
aged from 0 to 18 years were recruited in the study. Diagnosis of DSD was based on 
clinical features and hormonal profile.  
Results: Out of 100 patients, 71% had 46XY DSD, 24% had 46XX DSD, while sex 
chromosome DSD was identified in 5%. The median age of presentation was 12 months 




to either defect in androgen synthesis or action (40%) with the majority due to androgen 
insensitivity syndrome (28%). Most of the 46XX DSD (21/24) patients were diagnosed 
as classic congenital adrenal hyperplasia secondary to deficiency of 21 hydroxylase 
enzyme, with 90% being salt wasters. 
Conclusion: Our series revealed that 46XY DSD was the most frequent DSD 
aetiological diagnosis, with androgen insensitivity syndrome representing the 
commonest cause. CAH with classic salt wasting type was the second most common 
disorder. Management of children with DSD is challenging especially with lack of 
adequate resources. The crucial issues that stand against proper diagnosis and 
management are late presentation combined with economic constrains, and social and 
cultural issues.  
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Introduction 
Disorders of sex development (DSD) are rare congenital conditions that often create 
challenging circumstances for patients and their families in addition to health care 
providers [1].  
The Lawson Wilkins Paediatric Endocrine Society (LWPES) and the European Society 
for Paediatric Endocrinology (ESPE) in 2006 categorized causes of DSD according to 
karyotype analysis into three diagnostic categories: sex chromosome DSD, 46XY DSD, 
and 46XX DSD [2]. There are scarce data on the incidence of DSD, with an estimated 
overall incidence of 1:4500 to 1:5000 newborn [3]. In Egypt, the incidence of DSD was 
previously estimated at 1:3000 livebirths [4]. 
Although DSD are chiefly genetic congenital disorders, they could present later on in 
life and not only at birth [5]. DSDs are not only organic disorders but also represent a 
social emergency due to the possibility of failure of immediate sex assignment of the 
newborn. For that reason, management of patients with DSD must be accomplished by 
a skilled multidisciplinary team at a specialized centre [2]. Diagnosis of patients with 
DSD requires substantial diagnostic procedures. The first-line tests for accurate 
aetiological diagnosis are the genomic technologies [6]. However, application of these 




approval or national healthcare system coverage, and difficulties in the interpretation 
of the results; thus, diagnosis in limited resources countries depends mainly on 
hormonal tests and diagnostic imaging, which are less accurate [5]. 
There is a paucity of published data on this condition from Egypt. The aim of the current 
work is to review the clinical profile, aetiological classification, diagnosis, and 
management of Egyptian patients presenting with DSD at a tertiary centre in Cairo. 
 
Material and methods 
This was a cross-sectional observational study including 100 Egyptian patients who 
attended the Paediatric Endocrinology Clinic at the Children’s Hospital of Cairo 
University during a period of one year from January 2019 to December 2019. All 
patients with overt genital ambiguity and suspected to have DSD aged from 0 to 18 
years were recruited in the study. DSD was suspected in case of phenotypic male 
genitalia with non-palpable gonads, micropenis (defined as stretched penile length less 
than 2.5 standard deviations below the mean for age [7]), isolated penoscrotal or 
perineal hypospadias, apparent female genitalia with clitoromegaly, posterior labial 
fusion, inguinal/labial mass, or genital/karyotype discrepancy. 
Informed consent was obtained from patient’s guardians before inclusion in the study, 
and all of them agreed to participate. Thorough history was taken including the 
following: age at presentation, chief complaint, initial sex of rearing, family history of 
similar conditions, consanguinity, history of any medical problem, and history of any 
previous surgical intervention. Detailed clinical examination was done with rigorous 
genital examination including the size of phallus or clitoris, palpation of gonads, 
number and site of orifices, and labial/scrotal status, and then scoring them using the 
Prader Scale in virilized females [8] or the External Masculinization Score (EMS) in 
under-virilized males [9]. Additionally, assessment of any features of dysmorphism, or 
anomalies, and skin hyperpigmentation were recorded. 
The results of karyotype analysis for all patients were recorded. In addition, the 
hormonal and biochemical profiles for patients were recorded including the following: 
17- hydroxy progesterone (17-OHP), testosterone (T), androstenedione, 




adrenocorticotrophic hormone (ACTH). In patients in whom assessment of functioning 
testicular tissue was required, short human chorionic gonadotropin (hCG) stimulation 
test and measurement of anti-Müllerian hormone levels (AMH) were performed. The 
test is done by administrating 1500 units of hCG intramuscularly for three consecutive 
days, then a blood sample is collected 24 hours after the last dose for measurement of 
stimulated testosterone (T) and dihydrotestosterone (DHT). The response was 
considered adequate if the stimulated testosterone level climbed above the maximum 
cut-off for the normal pre-pubertal range or a rise of more than double the pre-
stimulatory value [10, 11]. Ratios of stimulated androgen values were used to 
presumably diagnose androgen biosynthetic defects. 5-alpha reductase deficiency was 
the supposed diagnosis if the ratio between stimulated testosterone/ DHT was greater 
than 30 [12]. However, a ratio between testosterone and androstenedione smaller than 
0.8 was suggestive of 17β-hydroxysteroid dehydrogenase (17β-HSD) deficiency [13]. 
Androgen insensitivity syndrome was diagnosed in any patient with 46XY karyotype 
with normal stimulated testosterone and DHT response with absent Müllerian 
remnants. It is divided into two types: partial or complete. Complete androgen 
insensitivity disorder was considered in patients who had completely normal female 
phenotype associated with the previously mentioned hormonal profile.  
In patients who had 46XX DSD, congenital adrenal hyperplasia was the first suspected 
diagnosis. Evaluation of the serum levels of 17(OH) progesterone, testosterone (T), 
androstenedione, dehydroepiandrosterone sulphate (DHEAS), 11 deoxycortisol, 
plasma renin activity, cortisol, and ACTH was done. Accordingly, the diagnosis of 
CAH with 21 hydroxylase deficiency was confirmed if 17-OHP levels > 100 ng/mL 
(300 nmol/L). Genetic analysis to confirm the diagnosis is not available at our centre. 
The results of radiological investigations (ultrasound or MRI) were retrieved from the 
patient’s records.  Surgical history including procedures and histological examination 
was reported. The aetiological classification of our cohort was based upon the suggested 
classification by the Lawson Wilkins Paediatric Endocrine Society (LWPES) and the 
European Society for Paediatric Endocrinology (ESPE) of 2006 [2]. The study protocol 







SPSS (Statistical Package for the Social Sciences, version 16; SPSS) software was used 
for data analysis. Descriptive analyses for numerical values were presented as mean ± 
standard deviation (SD) for parametric variables, and median and interquartile range 




The studied cohort comprised 100 patients who presented with any degree of genital 
ambiguity. Those patients represented 2% from a total number of 4870 patients who 
were attending the paediatric endocrinology clinic during the same year. The age of 
presentation ranged widely from 0.25 months to 204 months, with median age at 
presentation of 12 months. Nineteen (19%) patients presented during infancy and 60% 
of patients presented at age ≥ 12 months. Consanguinity was reported in nine (9%) 
patients. Five (5%) patients were found to have positive family history of affected 
siblings with similar condition.  
Karyotyping data was available for all recruited patients; accordingly, they were 
classified into 71 (71%) patients with 46XY DSD, 24 (24%) with 46XX DSD, and sex 
chromosome DSD in 5 (5%) patients. The aetiological classification of our patients is 
shown in Table 1. The most frequent aetiological diagnosis reported among the whole 
cohort was androgen insensitivity syndrome. However, congenital adrenal hyperplasia 
was the second most common aetiology. 
The DSD team consisted of a paediatric endocrinologist, a paediatric surgeon, a 
psychiatrist, and a geneticist. The team is responsible for clinical evaluation of the 
patients and setting up the management plan, which is shared with the parents. 
Concerning sex assignment, all patients were already assigned at the time of 
presentation to our centre. They were reared as 67 (67%) males and 33 (33%) females. 
However, after psychiatric evaluation and clinical diagnosis, 10 patients were 
reassigned. Seven patients among 46 of the XYDSD group and one patient among the 
sex chromosomal DSD group were finally reassigned as males. Two patients from the 





46XY DSD was the most frequently reported aetiology in our series, constituting 71% 
of the reported cohort. The most common cause of 46XY DSD was either a defect in 
androgen synthesis or action (40%) with the majority due to androgen insensitivity 
syndrome (28%). The chief complaint at presentation among the 46XY DSD group was 
genital ambiguity of variable degrees. This included: micropenis (45.1%), hypospadias 
(57.7%), underdeveloped bifid scrotum (35.2%), and impalpable gonads, whether 
unilateral (22.5%) or bilateral (36.6%).  
Three patients were diagnosed with complete androgen insensitivity (CAIS). Those 
patients presented in different age groups (6, 36, and 44 months) with completely 
normal female external genitalia and palpable swellings in the labial folds. They were 
reared as females.   
Partial androgen insensitivity (PAIS) was the presumed diagnosis in 25 patients. The 
age of presentation ranged from 1 month to 60 months, with a median age of 12 months. 
They presented with variable forms of undervirilization, mostly with penoscrotal 
hypospadias and bifid scrotum. The median EMS was 6 (range: 1 to 11). Four patients 
were reassigned as males after diagnosis; however, the rest of this group were reared as 
males since birth. 
Ten (10%) patients were diagnosed to have 5-alpha reductase deficiency. All of them 
were reared and continued as males.  
Disorder of testicular development was found in 10 (10%) patients. Vanishing testis 
syndrome was the diagnosis in two patients, partial gonadal dysgenesis in four patients, 
and four patients were diagnosed as ovotesticular DSD. 
The diagnosis of patients with ovotesticular DSD was based upon the results of 
laparoscopy and histopathologic examination of the gonadal biopsy. All of them had 
46XY karyotype. The detailed clinical profile is shown in Table 2. 
The two patients with vanishing testis syndrome were reared as males and presented 
with bilateral cryptorchidism, normal penile length, and normal urethral opening. The 
hormonal profile showed flat testosterone response after hCG stimulation, and low level 




of any gonad or any Müllerian structures. Both patients had other associated anomalies, 
with one of them having both cleft lip and palate and the other one having a congenital 
cataract. 
Persistent Müllerian duct syndrome was diagnosed in four (4%) patients. All of them 
had 46XY karyotype and were reared as males (Tab. 3). Ultrasound failed to visualize 
the Müllerian duct remnants (MDR) in three patients, but laparoscopy was the standard 
for diagnosis in all patients. Testosterone response was normal after hCG stimulation 
in all patients. The AMH level was normal in two patients but was not performed for 
the other two patients. Genetic testing for confirmation of the diagnosis is not available 
at our centre. Division of MDR was done in three patients because excision was not 
technically feasible and carries the risk of gonadal injury. Those patients were 
scheduled for regular follow up every six months to exclude any malignant 
transformation from the existing parts of Müllerian remnants. Excision of MDR was 
done in one patient.  
Isolated bilateral cryptorchidism was the presentation in 12 (12%) patients. Isolated 
anatomical defect was the diagnosis in seven patients after assessment of the hormonal 
profile (good hCG stimulated response and normal AMH). However, the other five 
patients had different diagnoses. One patient was diagnosed as pan hypopituitarism and 
presented at the age of three months with hypoglycaemic convulsions. The other 
patients were diagnosed as the following: Klinefelter syndrome, Robinow syndrome, 
Smith-Lemli-Opitz syndrome, and Kallmann syndrome. 
 
46XX DSD 
The majority of patients in the 46XX DSD (21/24) group were diagnosed as classic 
congenital adrenal hyperplasia (Tab. 1). Deficiency of 21 hydroxylase enzyme was the 
reported enzymatic defect in all patients based upon the biochemical analysis.  Nineteen 
patients had salt wasting type, and only two patients were simple virilizing. The median 
age at diagnosis of salt wasters was 0.25 months. All of them presented with salt losing 
crisis (severe dehydration, electrolyte disturbance, occasional hypoglycaemia). Five 
patients were found to have history of affected siblings with the same condition. One 




months. The degree of external genital virilisation according to Prader score was 
diverse: three patients had stage 2, 12 patients had stage 3, and the remaining six 
patients had stage 4. All patients were reared as females except two patients who were 
reassigned as females after diagnosis.  All patients underwent feminizing genitoplasty.  
Regarding patients with simple virilizing type, one of them presented at the age of 42 
months with clitoromegaly and hyperpigmentation. The other one presented at the age 
of 60 months with heterosexual pseudo precocious puberty.   
Two (2%) male patients presented with genital ambiguity in the form of unilateral 
undescended testis and proximal penile hypospadias. Their karyotyping was 46XX with 
negative SRY gene. Laparoscopic exploration and biopsy taken from the intra-
abdominal gonad showed testicular tissue, and laparoscopic orchidopexy was 
performed with subsequent diagnosis as testicular DSD (XX Sex reversal). 
 
Chromosomal DSD 
Sex chromosomal DSD was the aetiological diagnosis in five patients. Mixed gonadal 
dysgenesis was found in four patients with 45XO/46XY karyotype. The most common 
presentations of patients with mixed gonadal dysgenesis were unilateral or bilateral 
impalpable gonads with underdeveloped scrotal sac. The ages of presentation of 
patients who were reared as males were 6, 11, and 12 months. However, there was one 
patient who presented at the age of 54 months with complete normal female phenotype 
with two palpable inguinal swellings, and was reared as female.  
 
Discussion 
Giving birth to a newborn with abnormal genital development with unidentified sex is 
considered a social problem, and in some situations a medical emergency.           
In Egypt, the prevalence of DSD is unidentified, due to the absence of a nationwide 
registry. However, it was reported by Mazen et al. in 2010 [14] that the incidence of 





In the current series we included 100 patients who fulfilled the criteria of DSD. Those 
patients represented 2% from the total number of patients who were attending the 
endocrine clinic during the same period. The frequency of patients presenting with DSD 
in our cohort confirmed what was previously reported, i.e. that DSD is not an 
uncommon disorder among Egyptian children [14]. This large number of patients in a 
relatively short period (1 year) when compared to lower numbers in other previously 
published reports from other countries [15–17] highlights the extent of the problem of 
genital ambiguity in our community. This necessitates the establishment of a 
nationwide registry or larger multicentre studies to evaluate the actual prevalence and 
incidence of this problem. The prevalence of DSD among other African countries is not 
reported. However, a single-centre study in South Africa including 416 patients 
reported that the prevalence of DSD was 15.1% [18].  
According to the new classification of DSD by the Lawson Wilkins Paediatric 
Endocrine Society (LWPES) and the European Society for Paediatric Endocrinology 
(ESPE) [2], [19], our data revealed that the most common cause of DSD was 46XY 
DSD (71%), with 46XX DSD in second place (24%), and lastly chromosomal DSD 
(5%). According to previously published data from Egypt, 46XY DSD was also the 
most prevalent cause of DSD, representing 65.9% of all cases. It was concordant with 
results from other African countries; Ganie et al. in 2016 retrospectively reviewed 416 
children from South Africa presented with ambiguous genitalia with 57.5% of patients 
with 46 XY DSD [20]. Our finding is in contrast to other series of patients with DSD 
from Sudan, where 46XX DSD was the most common cause (57%) [21].  
In the 46XY DSD group, the most common cause was androgen insensitivity syndrome 
(28%). Out of them, 25 patients had partial androgen insensitivity syndrome, and three 
patients had complete androgen insensitivity syndrome. Furthermore, 10 patients (10%) 
were diagnosed as 5α reductase deficient. The proportion of patients with PAIS among 
our cohort is relatively high compared to what was reported by Mazen et al. in 2008, 
who found that 5α reductase deficiency is the most prevalent cause of defects of 
androgen synthesis and action [22]. We assume that this difference is caused by the 
diagnostic method used to differentiate between PAIS and 5α reductase deficiency 
among our cohort, which was based on hormonal assay (ratio between T/DHT>30). We 




patients with 46XY DSD in our series is the unavailability of molecular genetic analysis 
at our centre. 
It is well known worldwide that CAH is the most commonly reported cause of DSD 
[23]. In our series, CAH was the second most common cause of DSD (21%) among the 
whole group but the most prevalent aetiological diagnosis among the 46XX DSD group 
(90.5%). The classic form of CAH due to 21 hydroxylase deficiency was the only 
presenting form, with most patients being salt wasters (19/21). Most of those (15/19) 
patients were diagnosed during infancy. We suppose that the earlier age of diagnosis 
among this group, in spite of a lack of neonatal screening for CAH in Egypt, is due to 
the salt wasting manifestations associated with abnormal genitalia, which raise clinical 
suspicion, leading to earlier referral.  
 Sex chromosomal DSD was found to be the least frequent aetiological diagnosis among 
our cohort. Mixed gonadal dysgenesis with karyotype 45X, 46XY was the commonest 
cause in this category. 
Establishment of early diagnosis of DSD is crucial in sex assignment and decision-
making regarding the management plan. It is preferably accomplished immediately 
after delivery. Unfortunately, this was not the scenario in our series. The median age at 
presentation was 12 months, ranging from 0.25 months to 204 months. Only 19 patients 
(19%) presented during infancy, most of them (15%) being 46XX DSD. However, 60% 
of our patients presented at age ≥ 12 months. We assume that this late age of 
presentation was due to an improper genital examination by the general health 
professional attending the delivery. Additionally, the basic cytogenetic analysis and the 
hormonal profile, which are mandatory for the initial classification and diagnosis for 
patients with genital ambiguity, are not available except in a few tertiary hospitals in 
Egypt. Moreover, the early diagnosis is hindered not only by the lack of laboratory 
facility availability but also by the high expenses of those assays, which are not 
affordable to most patients. In addition to what was previously mentioned, the taboo 
associated with that condition in our society leads to a delay in seeking medical advice. 
Our reported age at presentation is relatively young compared to other reports from 
developing countries like India (87 months) [24] and Nigeria (20 months) [25]. 
However, other series from developed countries like Australia report earlier age of 




As regards sex of rearing, all patients with 46XX DSD were assigned as females from 
the start except for two patients who were reassigned after diagnosis. However, the sex 
of assignment among the 46XY DSD group is much more complicated. The preference 
of male sex assignment among our cohort was obvious even if the degree of 
undervirlization and the whole profile wwas not in favour of that. This is attributed to 
the strong impact of sociocultural beliefs among Egyptian society concerning marriage 
and future fertility, which could be prohibited by female sex. Long-term follow-up 
studies regarding the quality of life and fertility of such patients in our community are 
highly recommended, which could have an impact on clinical practice in the future.  
Interestingly, parental consanguinity was reported in only nine patients (9%). This is 
much less than was reported previously regarding the consanguinity rate among 
Egyptian children with DSD (62.8%) [22]. Also, this is less than the general 
consanguinity rate among Egyptian families, which ranged from 13.2% to 43.6% 
according to the region [27].  We assume that the different rate of consanguinity may 
be attributed to population selection bias reflecting the regional differences. 
Limitations 
The cross-sectional descriptive nature of this study conducted at a single centre during 
a short period (one year) are the main limitations. Additionally, the lack of molecular 
genetic analysis limited the decision regarding final diagnosis in many patients, 
especially those with 46XY DSD. The availability of the molecular analysis may 
change the aetiological classification of our cohort. Larger multicentre coordinated 
studies with long-term follow-up are needed to establish the actual prevalence and 




Our series revealed that 46XY DSD was the most frequent aetiological diagnosis, with 
androgen insensitivity syndrome representing the commonest presumed cause. CAH 
with classic salt wasting type was the second most common disorder, which highlights 




program. Management of children with DSD is a real challenge, especially with the 
lack of adequate resources. The crucial issues that stand against proper diagnosis and 
management are late presentation combined with economic constrains, and social and 
cultural issues. Finally, improvement of health care services provided for children with 
DSD necessitates a proper, continuous training program provided to paediatricians, and 
improving public health awareness regarding this problem, which facilitate early 
management and prevention of future critical crisis. 
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Table 1. Overview of aetiological classification and diagnosis of our cohort (n = 100) 
Aetiological classification Aetiological diagnosis N (%) 




 Disorder of androgen synthesis or action 
Androgen insensitivity syndromes  
 
5 alpha reductase deficiency 
 
20,22 desmolase deficiency 
 





Disorder of testicular development 
Ovotesticular DSD 
 
Partial gonadal dysgenesis 
 



















46XX DSD (n = 24) 
 Congenital adrenal hyperplasia  20 (20%) 
46XX testicular DSD (male sex reversal) 2 (2%) 
Others 
Vaginal atresia  
 
2 (2%) 
Sex chromosome DSD (n = 5) 
 Mixed gonadal dysgenesis (45XO/46XY DSD)  4 (4%) 
Klinefelter syndrome (47XXY) 1 (1%) 
  
Table 2. Clinical profile of patients with ovotesticular DSD (n = 4)  
Age 
(months) 









12 Bilateral impalpable gonads, underdeveloped 






7 Left impalpable gonad, asymmetrical labioscrotal 
folds, penoscrotal hypospadias, microphallus (1.5 
cm). 
Female Testis Ovary 
19 Left impalpable gonad, asymmetrical labioscrotal 
folds, penoscrotal hypospadias, microphallus (1 
cm). 
Female Testis Ovary 
16 Left impalpable gonad, underdeveloped scrotum, 
scrotal hypospadias, microphallus (1 cm) 
Male Testis Ovary 
 
Table 3. Clinical characteristics of patients with persistent Müllerian duct syndrome (n 
= 4)  






Genital examination Ultrasound findings Intervention 
10 Normal penile length with normal 
urethral opening 
Bilateral non palpable gonads with 
underdeveloped scrotum 
Visualized one testis, 






the gonads with 
biopsy proved 




MDRS and staged 
orchidopexy 
 
108 Normal penile length with normal 
urethral opening, 
Bilateral non palpable gonads with 
underdeveloped scrotum 




16 Micropenis with normal urethral 
opening 
Bilateral non palpable gonads with 
underdeveloped scrotum 
Visualized one testis, 




12 Micropenis with mid-shaft 
hypospadias  
Unilateral non-palpable gonad with 
well-developed scrotum 













Figure 1. Aetiological classification of disorders of sex development (DSD) 
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